Precision treatment for human epidermal growth factor receptor 2-amplified advanced rectal cancer: A case report
ICIs and pyrotinib may be effective in treating HER2-amplified advanced rectal cancer. Chemotherapy following disease progression could enhance efficacy synergistically.
Authors
- L. Wang
- Zhengyang Zhou (ORCID: https://orcid.org/0000-0002-9555-4617)
- Qingwen Wang (ORCID: https://orcid.org/0000-0002-9939-2707)
- Pei Huang (ORCID: https://orcid.org/0000-0003-3794-0162)
- Xiao Xia (ORCID: https://orcid.org/0000-0002-9268-6737)
Institutions
- Jiangnan University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.4251/wjgo.v17.i4.102690
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00